Form Type: 4

SEC EDGAR Link
Accession Number:0001192482-20-000128
Date:2020-02-03
Issuer: RECRO PHARMA, INC. (REPH)
Original Submission Date:

Reporting Person:

LAKE RYAN DAVID
C/O RECRO PHARMA, INC.
490 LAPP ROAD MALVERN, PA 19355

Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
Title of SecurityTransaction Date2a. Deemed Execution Date Transaction CodeSharesAcquired or DisposedPrice per share 5. Amount of Securities Beneficially Owned Following Reported Transaction 6. Ownership Form Direct or IndirectNature of Indirect Ownership
COMMON STOCK 2020-02-03 A 12,000 a $0.00 58,738 direct
Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, convertible securities
Title of Derivative Security Conversion or Exercise Price of Derivative Security Transaction Date Deemed Execution Date Transaction Code Number of Derivative Securities Acquired (A) or Disposed of (D) Date ExercisableExpiration Date Title and Amount of Securities Underlying Derivative Security Price of Derivative Security Number of derivative Securities Beneficially Owned Following Reported Transaction(s) Ownership Form: Direct (D) or Indirect (I) Nature of Indirect Beneficial Ownership
STOCK OPTION (RIGHT TO BUY) 16.62 2020-02-03 deemed execution date A 45,000 (a) 2030-02-03 common stock 45,000 $16.62 45,000 direct
Footnotes
IDfootnote
f1 all of the shares of common stock are represented by restricted stock units that will vest in four equal annual installments beginning february 3, 2021, subject to continued service to the company. vested shares will be delivered to the reporting person within 30 days following each respective vesting date.
f2 the stock option vests in equal monthly installments over 48 months, beginning on the date that is one month from the date of grant, subject to continued service to the company.
WhaleWisdom Logo

Elevate your investments